Genetic Modification of Human Induced Pluripotent Stem Cells (hiPSCs) by Lentiviral Transduction Protocol - Aligning Science Across Parkinson's

Research Community
Research Community

ASAP supports three programs and serves as a member of multiple consortia to advance research for the benefit of the global Parkinson’s disease community.
Explore
Highlights
Highlights

ASAP shares the impact that our initiative, network, and supported programs have had on providing new insights into Parkinson’s disease. Discover news, interviews, awards, and annual impact.
Explore
Open Science
Open Science

ASAP is dedicated to facilitating a research environment where meaningful collaboration, research-enabling resources, and data sharing provides the answers we need to understand, diagnose, and treat Parkinson’s disease. Discover our open science philosophy.
Explore
Tools & Resources
Tools & Resources

ASAP is committed to developing and openly sharing research outputs, including data, code, protocols, and key lab materials, to help the scientific community build upon existing work.
Explore

Description

This is the protocol for the genetic modification of human induced pluripotent stem cells (hiPSCs) using lentiviral transduction method.

Tags

Genetic models
Genetic targets
hiPSCs (Human induced pluripotent stem cells)

Discovery Team

Team Chen

Program

Collaborative Research Network

Theme

Neuro-Immune Interactions

Meet the Authors

Roshni Jaffery

External Collaborator
Ningbo Zheng

External Collaborator
Jiakai Hou

External Collaborator
Ashley Guerrero

External Collaborator
Si Chen

External Collaborator
Chunyu Xu

External Collaborator
Nicholas A. Egan

External Collaborator
Ritu Bohat

External Collaborator
Weiyi Peng, PhD

Co-PI (Core Leadership): Team Chen,

University of Houston